Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-018952)

Filing Details

Accession Number:: 0001209191-23-018952
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-03-15 17:20:08
Reporting Period:: 2023-03-14

Accepted Time:: 2023-03-15 17:20:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1176309	Oramed Pharmaceuticals Inc.	ORMP	Pharmaceutical Preparations (2834)	980376008

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1409232	Miriam Kidron	2 Elza Street Jerusalem L3 93706	Chief Scientific Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-03-14	100,000	$2.01	201,666	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

These shares were sold to a company owned solely by Nadav Kidron, a director and the president and chief executive officer of the Issuer, and the Reporting Person used the proceeds in connection with a personal tax payment.